Cleared Abbreviated

K140849 - ISOSEED

K140849 is an FDA 510(k) clearance for ISOSEED, manufactured by Eckert & Ziegler Bebig GmbH. The device is a Class 2 Radiology device with product code KXK cleared through the Abbreviated 510(k) pathway after a 90-day FDA review.

K140849 · Eckert & Ziegler Bebig GmbH · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
90d
Days
Class 2
Risk

K140849 is an FDA 510(k) clearance for the ISOSEED. Classified as Source, Brachytherapy, Radionuclide (product code KXK), Class II - Special Controls.

Submitted by Eckert & Ziegler Bebig GmbH (Berlin, DE). The FDA issued a Cleared decision on July 2, 2014 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Eckert & Ziegler Bebig GmbH devices

FDA 510(k) Submission Details - K140849

510(k) Number K140849 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2014
Decision Date July 02, 2014
Days to Decision 90 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 107d · This submission: 90d
Pathway characteristics
Standards-based clearance path.

KXK Device Classification - Class 2, Special Controls

Product Code KXK Source, Brachytherapy, Radionuclide
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KXK Source, Brachytherapy, Radionuclide

All 33
Devices cleared under the same product code (KXK) and FDA review panel - the closest regulatory comparables to K140849.
GammaTile
K190296 · Gt Medical Technologies · Mar 2019
GammaTile
K180515 · Isoray Medical, Inc. · Jul 2018
VariSeed 9.0
K150636 · Varian Medical Systems, Inc. · May 2015
BRACHYSOURCE SEED IMPLANTS WITH SOURCECAP BIOABSORBABLE CAPS
K140856 · C.R. Bard, Inc. · May 2014
BRACHYTHERAPY NEEDLES, RP SLEEVE, RP BRACHY-SPACER, GOLD MAKERS
K103449 · Riverpoint Medical · Feb 2011
RADIONUCLIDE BRACHYTHERAPY SOURCE
K093663 · C.R. Bard, Inc. · Dec 2009